American Society of Hirudotherapy

Correction to: Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches

Correction notice published in BMC Genomics (2020)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomics & ProteomicsSalivary PharmacologyBabenko VV et al. · BMC genomics, 2020

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticlePublished Erratum

Summary

Correction to the foundational Hirudo medicinalis draft genome and salivary transcriptome of H. medicinalis, H. orientalis, and H. verbana. Updates supplementary files and accession numbers.

Why This Matters for Hirudotherapy

This published erratum notice contains only a single statement: that an amendment to the original paper has been published and can be accessed via the original article. The abstract provides no substantive scientific data, no findings, no methodological details, and no information about genome sequences, salivary transcriptomes, or any leech-related content. Because the abstract is devoid of any standalone content, this item offers no direct scientific value for the domain of hirudotherapy or the leech secretome. The original article and its correction would need to be consulted directly for any relevant information.

Citation

Correction to: Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches.

Babenko VV et al. · BMC genomics, 2020

DOI

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.